NO975747D0 - Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler - Google Patents

Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler

Info

Publication number
NO975747D0
NO975747D0 NO975747A NO975747A NO975747D0 NO 975747 D0 NO975747 D0 NO 975747D0 NO 975747 A NO975747 A NO 975747A NO 975747 A NO975747 A NO 975747A NO 975747 D0 NO975747 D0 NO 975747D0
Authority
NO
Norway
Prior art keywords
thrombin
treatment
related deficiencies
peptidyl
heterocycles
Prior art date
Application number
NO975747A
Other languages
English (en)
Other versions
NO975747L (no
Inventor
Michel J Costanzo
Bruce E Maryanoff
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO975747D0 publication Critical patent/NO975747D0/no
Publication of NO975747L publication Critical patent/NO975747L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO975747A 1995-06-07 1997-12-05 Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler NO975747L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/486,473 US5523308A (en) 1995-06-07 1995-06-07 Peptidyl heterocycles useful in the treatment of thrombin related disorders
PCT/US1996/008456 WO1996040748A1 (en) 1995-06-07 1996-06-03 Peptidyl heterocycles useful in the treatment of thrombin related disorders

Publications (2)

Publication Number Publication Date
NO975747D0 true NO975747D0 (no) 1997-12-05
NO975747L NO975747L (no) 1998-02-03

Family

ID=23932026

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975747A NO975747L (no) 1995-06-07 1997-12-05 Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler

Country Status (21)

Country Link
US (1) US5523308A (no)
EP (1) EP0833839B1 (no)
JP (1) JPH11506762A (no)
KR (1) KR100434667B1 (no)
CN (1) CN1146575C (no)
AT (1) ATE230757T1 (no)
AU (1) AU721079B2 (no)
CA (1) CA2224110A1 (no)
CZ (1) CZ386997A3 (no)
DE (1) DE69625691T2 (no)
DK (1) DK0833839T3 (no)
ES (1) ES2191102T3 (no)
IL (1) IL122436A (no)
MX (1) MX9709915A (no)
NO (1) NO975747L (no)
NZ (1) NZ309523A (no)
PL (1) PL184986B1 (no)
RU (1) RU2181125C2 (no)
TW (1) TW470751B (no)
WO (1) WO1996040748A1 (no)
ZA (1) ZA964759B (no)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857633A (en) * 1984-06-25 1989-08-15 Exxon Research & Engineering Company Method for high temperature phase separation of solutions containing polymers
US5827866A (en) * 1995-06-07 1998-10-27 Ortho Pharmaceutical Corporation Peptidyl heterocycles useful in the treatment of thrombin related disorders
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US6211154B1 (en) 1995-06-07 2001-04-03 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5827860A (en) * 1995-06-07 1998-10-27 Ortho Pharmaceutical Corporation Peptidyl heterocycles useful in the treatment of thrombin related disorders
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
IL119466A (en) * 1995-11-03 2001-08-26 Akzo Nobel Nv Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
US5811402A (en) * 1996-03-22 1998-09-22 Eli Lilly And Company Antithrombotic diamides
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6194435B1 (en) * 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
AU743735B2 (en) * 1996-10-11 2002-02-07 Millennium Pharmaceuticals, Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
WO1998016524A1 (en) * 1996-10-11 1998-04-23 Cor Therapeutics, Inc. HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS
EP0932608A1 (en) * 1996-10-11 1999-08-04 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
JP2001521524A (ja) * 1997-04-14 2001-11-06 シーオーアール セラピューティクス インコーポレイテッド 選択的Ｘａ因子阻害剤
CA2285685A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. Selective factor xa inhibitors
EP0977773A1 (en) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US5877156A (en) * 1997-04-24 1999-03-02 Akzo Nobel, N.V. Thrombin inhibitors
EP0884325A1 (en) * 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
WO1998051684A1 (en) * 1997-05-15 1998-11-19 Eli Lilly And Company Antithrombotic compound
AU2006252275A1 (en) * 1997-07-28 2007-01-25 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8039026B1 (en) * 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
TR200102766T2 (tr) * 1999-01-27 2001-12-21 Ortho-Mcneil Pharmaceutical, Inc. Triptaz inhibitörü olarak kullanılan peptidil heterosiklik ketonlar
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
SI20582A (sl) 2000-05-05 2001-12-31 Univerza V Ljubljani Novi inhibitorji trombina, njihova priprava in uporaba
US6960597B2 (en) * 2000-06-30 2005-11-01 Orth-Mcneil Pharmaceutical, Inc. Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
KR20030080810A (ko) * 2002-04-11 2003-10-17 주식회사 엘지생명과학 아미노피리도아릴 그룹을 가진 선택적 트롬빈 억제제
MXPA04010089A (es) * 2002-04-16 2004-12-13 Axys Pharm Inc Proceso para preparar reactivos de heteroarilo y heterocicloalquilmagnesio insaturado y sus usos.
US7375093B2 (en) * 2002-07-05 2008-05-20 Intrexon Corporation Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US20040063593A1 (en) * 2002-09-30 2004-04-01 Wu Jeffrey M. Compositions containing a cosmetically active organic acid and a legume product
US7393920B2 (en) 2003-06-23 2008-07-01 Cem Corporation Microwave-assisted peptide synthesis
US20050176755A1 (en) * 2003-10-31 2005-08-11 Dyatkin Alexey B. Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
US20050209232A1 (en) * 2004-02-10 2005-09-22 Kent Barbay Pyridazinone ureas as antagonists of alpha4 integrins
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
PT2019837E (pt) * 2006-05-23 2011-07-05 Irm Llc Compostos e composições como inibidores das proteases activadoras de canal
AU2007253819B2 (en) 2006-05-23 2011-02-17 Irm Llc Compounds and compositions as channel activating protease inhibitors
TWI389899B (zh) * 2006-08-08 2013-03-21 Msd Oss Bv 具口服活性之凝血酶抑制劑
CA2677487A1 (en) * 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
JP2010518097A (ja) * 2007-02-09 2010-05-27 アイアールエム・リミテッド・ライアビリティ・カンパニー チャネル活性化プロテアーゼ阻害剤としての化合物および組成物
ES2676412T3 (es) * 2011-06-02 2018-07-19 Socpra Sciences Santé Et Humaines S.E.C. Inhibidores de matriptasa y usos de los mismos contra infecciones por ortomixovirus
CN104003984B (zh) * 2014-06-16 2016-03-02 山东大学 噻唑-4-甲酰基哌嗪衍生物及其制备方法与应用
ES2819218T3 (es) * 2014-10-06 2021-04-15 Cortexyme Inc Inhibidores de lisina gingipaína
JP6877424B2 (ja) * 2015-11-09 2021-05-26 コーテクシーミー， インコーポレイテッド アルギニンジンジパインの阻害剤
KR20190072530A (ko) 2016-09-16 2019-06-25 코텍자임, 인코포레이티드 리신 진지파인의 케톤 억제제
US20190309020A1 (en) * 2016-11-22 2019-10-10 Ohio State Innovation Foundation Cell-penetrating peptide sequences

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503203A1 (en) * 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors
DK0626968T3 (da) * 1992-02-13 2001-12-31 Merrell Pharma Inc Thiacykliske piperidinylderivater
JPH0820597A (ja) * 1994-07-07 1996-01-23 Meiji Seika Kaisha Ltd トロンビン阻害作用を有する複素環カルボニル化合物

Also Published As

Publication number Publication date
JPH11506762A (ja) 1999-06-15
EP0833839A1 (en) 1998-04-08
DE69625691T2 (de) 2003-10-23
TW470751B (en) 2002-01-01
CZ386997A3 (cs) 1998-07-15
ES2191102T3 (es) 2003-09-01
CN1192747A (zh) 1998-09-09
PL323825A1 (en) 1998-04-27
WO1996040748A1 (en) 1996-12-19
RU2181125C2 (ru) 2002-04-10
ZA964759B (en) 1997-12-08
KR19990022568A (ko) 1999-03-25
IL122436A (en) 2004-06-20
EP0833839B1 (en) 2003-01-08
MX9709915A (es) 1998-08-30
PL184986B1 (pl) 2003-01-31
US5523308A (en) 1996-06-04
KR100434667B1 (ko) 2004-09-24
ATE230757T1 (de) 2003-01-15
NZ309523A (en) 1999-11-29
AU5971396A (en) 1996-12-30
DK0833839T3 (da) 2003-04-14
AU721079B2 (en) 2000-06-22
CN1146575C (zh) 2004-04-21
DE69625691D1 (de) 2003-02-13
CA2224110A1 (en) 1996-12-19
NO975747L (no) 1998-02-03

Similar Documents

Publication Publication Date Title
NO975747D0 (no) Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
FI934223A0 (fi) Heterocykliscykliska aminderivat
AU6613896A (en) Chemical compounds
CY2006007I2 (el) Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
AR038431A2 (es) Derivados 2-desoxo-15-alquilo de marcfortina
NO986054L (no) Antikonvulsivt virkende derivater til bruk ved behandling av amyotrofisk lateral sklerose (ALS)
ATE320804T1 (de) Behandlung negativer und kognitiver symptome der schizophrenie mit antagonisten der glycinaufnahme
NZ335981A (en) Ketobenzamides as calpain inhibitors
DE59702414D1 (de) Dipeptidische benzamidine als kininogenasen-inhibitoren
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
DE69612465T2 (de) Verwendung von Rifamyciderivaten zur Behandlung von Chlamydia-Infektionen
FI972919A (fi) Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
EP0909561A3 (en) Use of reboxetine for the treatment of attention-deficit/hyperactivity disorder
AU5967896A (en) Peptidyl heterocycles useful in the treatment of thrombin re lated disorders
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
FR2777291B1 (fr) Nouvelle metalloprotease membranaire nep ii et son utilisation pour le criblage d'inhibiteurs utiles en therapie
NO975488D0 (no) Anvendelse av pyrrolidinderivater ved behandling av alkoholisme
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
ZA969586B (en) The use of cholinesterase inhibitors in the treatment of xerostomia
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
FR2758135B1 (fr) Procedes et dispositifs pour la desinfection et le recyclage d'un effluent aqueux

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application